JULI DYER: Open Payments
NPI 1437430352 · OAKWOOD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 37 payments from 17 companies in 2025. Trend: 2023 $983 · 2024 $699 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 1 | $148 |
| Novo Nordisk Inc | 7 | $127 |
| Inspire Medical Systems, Inc. | 1 | $84 |
| ABBVIE INC. | 4 | $67 |
| Exact Sciences Corporation | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: Attruby, INSPIRE, Cologuard Collection Kit, REXULTI, VRAYLAR, MOUNJARO, AIRSUPRA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
